Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.
|Videos|July 26, 2022
Fezolinetant making waves for VMS
Author(s)Morgan Ebert
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).
Advertisement
Advertisement
Related to this article
A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.
A recap of Contemporary OB/GYN's top FDA and regulatory news from September 2026.
Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
Menopause proteomics were consistently associated with inflammatory brain aging and Alzheimer’s dementia risk across nearly 15,000 women in a new study published in Nature Medicine.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
A new Gallup survey found 51% of women in the United States reported negative healthcare experiences.
The FDA office of Women's Health and Center for Drug Evaluation and Research and hosting a public workshop with a focus on testosterone use in menopausal women.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
Gestational hypertension rose 73% from 2016 to 2024, CDC data show
3
Contemporary OB/GYN's top expert interviews from September 2026
4
Low birth volume and unprofitability associated with obstetric services losses
5